Skip to main content
OSE Immunotherapeutics logo

OSE Immunotherapeutics — Investor Relations & Filings

Ticker · OSE ISIN · FR0012127173 LEI · 969500HIUWVGY6NZSM05 PA Manufacturing
Open in API
Filings indexed 815 across all filing types
Latest filing 2025-06-19 Major Shareholding Noti…
Country FR France
Listing PA OSE

About OSE Immunotherapeutics

https://www.ose-immuno.com/en/home/

OSE Immunotherapeutics is a clinical-stage biotechnology company focused on developing and partnering first-in-class therapies that control the immune system. The company's pipeline is concentrated in two key areas: immuno-oncology (IO) and immuno-inflammation (I&I). In immuno-oncology, its research aims to help the immune system recognize and target tumors. In immuno-inflammation, it develops treatments for autoimmune diseases and chronic inflammation by regulating immune responses. OSE Immunotherapeutics utilizes proprietary drug discovery platforms to generate novel product candidates, including monoclonal antibodies and RNA therapeutics, and collaborates with pharmaceutical partners to advance its assets through clinical development.

Recent filings

Filing Released Lang Actions
Franchissement de seuils et déclaration d'intention
Major Shareholding Notification Classification · 100% confidence The document is an official notice from the Autorité des Marchés Financiers (AMF) regarding a 'Déclaration de franchissement de seuils' (threshold crossing notification) and 'déclaration d'intention' (declaration of intent) by a group of shareholders acting in concert. This type of filing is specifically designed to notify the market of significant changes in shareholding ownership and the strategic intentions of the shareholders involved, which falls under the category of Major Shareholding Notification.
2025-06-19 French
AJOURNEMENT DE L’ASSEMBLÉE GÉNÉRALE INITIALEMENT CONVOQUEE POUR LE 25 JUIN 2025
AGM Information Classification · 95% confidence The document is a press release announcing the *adjournment* (cancellation and rescheduling) of the Annual General Meeting (Assemblée Générale) originally set for June 25, 2025. It explicitly states that the Board of Directors will convene a new General Meeting later and that previously received proxy forms are void. While the subject matter relates to the AGM, the document itself is an official announcement regarding the procedural status of the meeting, not the presentation materials (AGM-R) or the proxy solicitation materials (PSI). Since it is an official corporate announcement concerning a procedural matter related to a shareholder meeting, and it is not a standard financial report (like 10-K or IR), it fits best under the general category for official regulatory announcements or specific procedural notices. Given the options, this is a specific announcement about the meeting process, which is closely related to AGM procedures. However, it is not the AGM presentation itself (AGM-R) nor the proxy materials (PSI). It is an announcement about the *postponement* of the meeting. Since it is a formal communication regarding shareholder meetings and voting rights procedures, and it is not a standard financial report, it is most closely related to AGM/Shareholder matters. Given the available codes, AGM-R is for the meeting materials themselves. Since this is an announcement *about* the meeting's status, and it is a formal corporate communication, it is best classified as a general regulatory announcement (RNS) or potentially related to AGM-R if interpreted broadly. However, the core topic is the AGM postponement. If we look at the definitions, AGM-R is for presentations/materials *shared during* the AGM. This is an announcement *before* the rescheduled AGM. Given the nature of the announcement (postponement due to legal proceedings related to the meeting), it is a formal corporate action announcement. RNS is the fallback for miscellaneous regulatory filings. Since the document is a formal press release announcing a significant procedural change regarding the AGM, and it doesn't fit perfectly into AGM-R (materials *at* the meeting) or PSI (proxy solicitation), RNS (General regulatory announcements) is the most appropriate catch-all for this type of formal procedural update, although it strongly relates to shareholder meetings.
2025-06-11 French
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025
AGM Information Classification · 98% confidence The document explicitly announces the 'ADJOURNMENT OF THE GENERAL MEETING' initially scheduled for June 25, 2025. It discusses the cancellation of the convening, the extension of the legal deadline granted by the court, and states that proxy forms received are void and new information regarding the 'new convocation, agenda, resolution texts, and participation and voting procedures will be communicated in due course.' This content directly relates to the procedures and announcements surrounding a shareholder meeting, specifically concerning voting and meeting logistics, which aligns best with the 'AGM Information' category, even though it is an announcement about postponement rather than the final meeting materials themselves. Since the core subject is the General Meeting, AGM-R is the most appropriate classification over a general regulatory filing (RNS) or a proxy solicitation document (PSI), as it is an official announcement regarding the meeting's status.
2025-06-11 English
MISE À JOUR DES MODALITÉS DE L’ASSEMBLÉE GÉNÉRALE
AGM Information Classification · 98% confidence The document is explicitly titled "MISE À JOUR DES MODALITÉS DE L'ASSEMBLÉE GÉNÉRALE" (Update on the Terms of the General Meeting) and discusses the postponement request for the General Meeting scheduled for June 25, 2025, due to shareholder resolution disputes. This content directly relates to the procedures, materials, and updates concerning the Annual General Meeting (AGM). Therefore, the most appropriate classification is AGM Information (AGM-R). Although it is an update, it is not merely an announcement of a report (RPA) but substantive information regarding the meeting itself.
2025-06-09 French
UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING
AGM Information Classification · 98% confidence The document is titled "UPDATE ON THE TERMS OF THE SHAREHOLDERS GENERAL MEETING" and discusses the postponement of the Combined General Meeting scheduled for June 25, 2025, due to shareholder resolution disputes and the need to secure the voting process. This content directly relates to the procedures, materials, and updates concerning the Annual General Meeting (AGM). Although it is an update/press release, its core subject matter is the AGM itself, making 'AGM Information' (AGM-R) the most specific category. It is not a full report (10-K, IR), a proxy statement (PSI), or just a general announcement (RPA/RNS), as it details specific procedural changes related to the meeting's conduct.
2025-06-09 English
Informations relatives au nombre total de droits de vote et d’actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Informations relatives au nombre total de droits de vote et d'actions composant le capital" (Information relating to the total number of voting rights and shares comprising the capital). It explicitly states it is being issued in application of the French Commercial Code (Article L. 233-8 II) and AMF General Regulation (Article 223-16). It provides a table detailing the total number of shares and voting rights as of May 31, 2025. This content directly relates to the structure of the company's capital and voting rights, which aligns best with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it is a mandatory disclosure regarding the total voting power, even if it's not the result of a specific vote, it is a formal declaration related to voting rights structure. It is not an AGM presentation (AGM-R), a general earnings release (ER), or a management report (MDA). Given the specific nature of reporting total voting rights as required by regulation, DVA is the most precise fit among the provided options.
2025-06-05 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.